Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

The man's symptoms improved significantly after penicillin treatment for syphilis.

Finasteride doesn't harm quality of life.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Men with enlarged prostates often have more severe baldness.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Finasteride is effective and safe.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Finasteride side effects in young men may be linked to specific gene variations.

Androgen, especially DHT, is crucial for erectile function in rats by affecting specific brain neurons.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.